BioSpace News Archive

Amber Bio, a biotechnology company pioneering multi-kilobase gene editing platforms to reach previously undruggable diseases, launched with an oversubscribed $26 million seed financing round co-led by Playground Global and Andreessen Horowitz Bio + Health.

Bio-Path Holdings, Inc. announced the pricing of a public offering of 3,500,000 shares of common stock, together with accompanying common stock purchase warrants, at a price to the public of $0.60 per share and accompanying common stock purchase warrant, for aggregate gross proceeds to the Company of approximately $2.1 million, before deducting the fees and estimated offering expenses payable by the Company.

GRI Bio, Inc. today announced that Marc Hertz, PhD, President and Chief Executive Officer will participate in a fireside chat at Benzinga’s Virtual Biotech Conference on Thursday, August 3, 2023 at 11:15 AM ET.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company’s founder, president and CEO, is presenting at an invitation-only lunch gathering of the Wall Street Wonders Investment Group in New York City at 1:30 p.m. EDT on Friday August 4, 2023.

Femasys Inc. announced the initiation of enrollment in a prospective multi-center pivotal trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control (the “FINALE” trial), to investigate the safety and efficacy of its investigational permanent birth control candidate, FemBloc®.

Moleculin Biotech, Inc. today announced that it will report its financial results for the second quarter ended June 30, 2023 , on Friday, August 11, 2023.

Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors.

Elevar Therapeutics, Inc. today announced it will host a virtual key opinion leader (KOL) event on August 10, 2023, at 10 a.m. ET to discuss the Phase 3 study of rivoceranib in combination with camrelizumab in unresectable hepatocellular carcinoma (uHCC).

BioSkryb Genomics, a pioneer in comprehensive single-cell multiomic research solutions, optimized a high-throughput workflow of BioSkryb’s ResolveDNA® Single-Cell Whole Genome Amplification technology on HP’s new D100 Single Cell Dispenser to deliver single-cell genomics at scale.

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates and results for its third quarter of the fiscal year 2023 ended on June 30, 2023, on August 14, 2023, beginning at 1:30 pm PT.